- Title
- Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis
- Creators
- Bao Ying Chen - University of California, Los AngelesJessica R Salas - University of California, Los AngelesAlyssa O Trias - University of California, Los AngelesArely Perez RodriguezJonathan E Tsang - University of California, Los AngelesMiriam Guemes - University of California, Los AngelesThuc M Le - University of California, Los AngelesZoran Galic - University of California, Los AngelesH Michael Shepard - Enosi Life Sciences, Eugene, OR, USA.Lawrence Steinman - Stanford UniversityDavid A Nathanson - University of California, Los AngelesJohannes Czernin - University of California, Los AngelesOwen N Witte - Broad CenterCaius G Radu - University of California, Los AngelesKenneth A Schultz - Trethera Corporation, Sherman Oaks, CA, USA.Peter M Clark - University of California, Los Angeles
- Publication Details
- Immunology
- Publisher
- Wiley
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems; Drexel University
- Web of Science ID
- WOS:000849521800001
- Scopus ID
- 2-s2.0-85137373480
- Other Identifier
- 991019356344304721
Journal article
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis
Immunology
20 Aug 2022
PMID: 35986643
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Immunology